Skip to main content
All lobbying filings

AMERICAN CLINICAL LABORATORY ASSN

Lobbying for AMERICAN CLINICAL LABORATORY ASSN

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $930,000.00 expenses · posted Jan 16, 2026

Official filing document

 Bills named in this filing 2
 Lobbying activity 3
Medical/Disease Research/Clinical Labs

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform.

Medicare/Medicaid

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93).

Health Issues

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostics regulatory reform; price transparency requirements for clinical laboratory services.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem